| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | William H Robinson | |
| Tamsin M Lindstrom | |||
| P2860 | cites work | Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset | Q24792419 |
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Use of multiple biomarkers to improve the prediction of death from cardiovascular causes | Q28280099 | ||
| Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity | Q28306204 | ||
| Converting a breast cancer microarray signature into a high-throughput diagnostic test. | Q33262104 | ||
| An eight-gene blood expression profile predicts the response to infliximab in rheumatoid arthritis. | Q33511764 | ||
| Serum protein markers for early detection of ovarian cancer | Q33836343 | ||
| A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis | Q33982255 | ||
| Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug | Q34139151 | ||
| HER-2-targeted therapy: lessons learned and future directions. | Q34276302 | ||
| Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis | Q34327451 | ||
| Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis | Q34498921 | ||
| Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis | Q34650192 | ||
| Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis | Q35073922 | ||
| Clinical utility of the anti-CCP assay in patients with rheumatic diseases | Q35553110 | ||
| Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). | Q35554533 | ||
| Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis | Q35605604 | ||
| EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | Q35638360 | ||
| Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis | Q36192796 | ||
| Protein biomarker discovery and validation: the long and uncertain path to clinical utility | Q36561644 | ||
| Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers | Q36767490 | ||
| Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis | Q37000109 | ||
| Antibodies to citrullinated proteins in arthritis: pathology and promise | Q37128331 | ||
| Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis | Q37270792 | ||
| Evidence that cytokines play a role in rheumatoid arthritis | Q37316594 | ||
| Recent progress in rheumatoid arthritis genetics: one step towards improved patient care | Q37443734 | ||
| A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. | Q37480830 | ||
| Clinical approaches to early inflammatory arthritis | Q37604880 | ||
| Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors | Q40532147 | ||
| Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study | Q43903137 | ||
| Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis | Q44210170 | ||
| Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study | Q44213841 | ||
| Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis | Q44616885 | ||
| Antigen microarray profiling of autoantibodies in rheumatoid arthritis. | Q46107435 | ||
| Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings | Q57570391 | ||
| How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis | Q57789144 | ||
| Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients | Q67546236 | ||
| Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein | Q73502940 | ||
| Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study | Q79328295 | ||
| Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition | Q81216018 | ||
| C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept | Q81248096 | ||
| Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis | Q81445112 | ||
| Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis | Q82704607 | ||
| P921 | main subject | rheumatoid arthritis | Q187255 |
| biomarker | Q864574 | ||
| precision medicine | Q17075943 | ||
| P304 | page(s) | 79-84 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | The Scandinavian journal of clinical & laboratory investigation. Supplementum | Q26841959 |
| P1476 | title | Biomarkers for rheumatoid arthritis: making it personal | |
| P478 | volume | 242 |
| Q92898086 | A Clinician's Perspective on Biomarkers |
| Q35739516 | A proteomic profile of synoviocyte lesions microdissected from formalin-fixed paraffin-embedded synovial tissues of rheumatoid arthritis |
| Q51075481 | Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis. |
| Q64885080 | CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis. |
| Q47737994 | Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis. |
| Q95269819 | Composite contributions of cerebrospinal fluid GABAergic neurosteroids, neuropeptide Y and interleukin-6 to PTSD symptom severity in men with PTSD |
| Q35470652 | Current and future trends in biomarker discovery and development of companion diagnostics for arthritis. |
| Q34811313 | Detection of inflammatory arthritis by using hyperpolarized 13C-pyruvate with MR imaging and spectroscopy |
| Q38797638 | Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis. |
| Q36503454 | Fibronectin molecular status determination useful to differentiate between rheumatoid arthritis and systemic lupus erythematosus patients |
| Q92146862 | Identification of pathological RA endotypes using blood-based biomarkers reflecting tissue metabolism. A retrospective and explorative analysis of two phase III RA studies |
| Q45087618 | Interleukin-1 receptor antagonist gene polymorphism and hepcidin in rheumatoid arthritis: Correlations with clinical and laboratory indices of disease activity. |
| Q41685093 | Juggling Art: Making Critical Clinical Decisions without Vital Laboratory Support in Autoimmune Rheumatic Patients in a Resource Poor Setting |
| Q28084913 | Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy |
| Q39658675 | Potential biomarkers of haemophilic arthropathy: correlations with compatible additive magnetic resonance imaging scores |
| Q35691806 | Pretreatment Prediction of Individual Rheumatoid Arthritis Patients' Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers |
| Q31158874 | Serum inflammatory mediators as markers of human Lyme disease activity |
| Q33766404 | Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. |
| Q39431367 | Synovial tissue research: a state-of-the-art review |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.